Our studies specifically evaluated galectin-1 and -3 due to the evidence suggesting that these two galectin family members are directly involved in the pathogenesis of arthritis and may serve as potential therapeutic targets for OA and RA27, 42, 43, 47. Here, LGALS1 is linked to arthritic joint disease.